PEAK6’s Cellebrite CLBT Stock Holding History

PEAK6’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,608	Closed	-$711K	–	2790
2026 Q1	$711K	Buy	+51,608	New	+$778K	﹤0.01%	1847
2025 Q2	–	Sell	-55,465	Closed	-$1.08M	–	3040
2025 Q1	$1.08M	Buy	55,465 +23,366	+73%	+$492K	﹤0.01%	1725
2024 Q4	$707K	Buy	+32,099	New	+$618K	﹤0.01%	1982

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

PEAK6's CLBT Position: Q2 2026 in Review

PEAK6 sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 51,608 shares — an estimated $711K sold.

PEAK6 first reported a position in CLBT in Q4 2024 and held it in 3 quarters. The position peaked at $1.08M in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

PEAK6 reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
PEAK6 sold 51,608 Cellebrite shares in Q2 2026, an estimated $711K.
PEAK6 first reported a position in Cellebrite in Q4 2024 and held it in 3 quarters.
PEAK6's Cellebrite position peaked at $1.08M in Q1 2025.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.